Colorado plans to limit insurance coverage for weight-loss drugs like Wegovy and Ozempic for thousands of state employees.

The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

“Improving prescription drug affordability for Medicare enrollees is the core of the Inflation Reduction Act, and the next ...

A class of drugs designed to fight diabetes and weight loss can help with a host of other problems, but also carry some side ...

Research shows that GLP-1 receptor agonists like Ozempic can help you drop weight, manage diabetes, and even potentially ...

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

The drugs account for $41 billion in annual Medicare spending, the Biden administration said.

Novo Nordisk shares jumped on Friday as the Danish drugmaker said an experimental drug was able to reduce weight by as much ...

Novo Nordisk (NVO) stock jumped 12% in pre-market trading Friday after it released promising results of an early-stage weight ...

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...